Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
The new sharewise is here Clearer, faster, with a light and a dark view — and everything you already know. Try it now
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
  1. Predictions
buy

EyePoint Pharmaceuticals Inc. buy Royal Bank of Canada

EyePoint Pharmaceuticals Inc.
Start price
€11.30
07.05.26 / 50%
Target price
€31.47
07.05.27
Performance (%)
-7.96%
Price
€10.10
06.08.26
Summary
This prediction is currently active. With a performance of -7.96%, the BUY prediction by Royal_Bank_of_Canada is trending in the wrong direction. This prediction currently runs until 07.05.27. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this prediction
Performance without dividends (%)
Name 1w 1m
EyePoint Pharmaceuticals Inc. 2.020% 2.020%
iShares Core DAX® 2,57 % 3,50 %
iShares Nasdaq 100 4,86 % 0,65 %
iShares Nikkei 225® 5,59 % -0,25 %
iShares S&P 500 3,25 % 2,08 %

Comments by Royal_Bank_of_Canada for this prediction

In the thread EyePoint Pharmaceuticals Inc. diskutieren
Prediction Buy
Perf. (%) -7.96%
Target price 31.472
Change
Ends at 07.05.27

Eyepoint Pharmaceuticals (EYPT) had its price target lowered by Royal Bank Of Canada from $39.00 to $37.00. They now have an "outperform" rating on the stock.
Ratings data for EYPT provided by MarketBeat

Royal Bank of Canada 
0
Report Share
07.05.26

Stopped prediction by Royal_Bank_of_Canada for EyePoint Pharmaceuticals Inc.

buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€9.59
06.11.25
€33.89
06.11.26
25.10%
06.08.26

Royal Bank of Canada 
06.11.25 50%
buy
EyePoint Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€8.18
17.06.25
€24.24
17.06.26
40.62%
18.06.26

Royal Bank of Canada 
17.06.25 50%